5 Best Rated Penny Stocks to Buy According to Analysts

Page 1 of 5

In this article, we will take a look at the 5 best rated penny stocks to buy according to analysts. To see more such companies, go directly to 10 Best Rated Penny Stocks to Buy According to Analysts.

5. Affimed NV (NASDAQ:AFMD)

Analyst Price Target: $6.00

Upside Potential: 837.50%

Germany-based Affimed is trading at $0.64 as of July 13, while its analyst price target is $6. This stock price target shows an upside potential of a whopping 837% from the current levels. The company is working on treatments of lymphoma.

In May the stock jumped after the company announced the FDA cleared an Investigational New Drug Application (IND) permitting a Phase 2 trial to study its innate cell engager AFM13 in a combination therapy for certain patients with Hodgkin Lymphoma.

As of the end of the first quarter of 2023, 12 hedge funds were long AFMD. The most notable hedge fund stakeholder of the company was 683 Capital Partners of Ari Zweiman which had a $6.7 million stake in the company.

Page 1 of 5